Prof. Miriam Colombo obtained her Master’s degree in Medicinal Chemistry and Technology from the University of Milan in 2008 and earned her PhD in Biology in 2012. She is Full Professor of Clinical Biochemistry at the University of Milano-Bicocca. Her research focuses on the development of nanotechnology-based platforms for biomedical applications, with particular emphasis on nanomedicine approaches for the treatment of breast cancer. Her work encompasses the design, synthesis, characterization, and biofunctionalization of innovative nanocarriers for targeted drug delivery, RNA-based therapies, and cancer immunotherapy. She has also investigated alternative administration routes for nanoparticles and biomolecules, including oral and topical delivery strategies, aiming at improving therapeutic efficacy and patient compliance. In parallel, she applies nanotechnology and advanced formulation approaches to the cosmetic field, focusing on the development and characterization of innovative cosmetic ingredients, nanoformulations, and delivery systems for topical and oral applications. Her research integrates nanomedicine, pharmaceutical technology, and cosmetic science to develop next-generation formulations with enhanced bioactivity and targeted delivery properties. Prof. Colombo is the author of more than 100 peer-reviewed scientific publications and has an h-index of 41.